Skip to main content
News

News  Circular letter: 17-1-666 Massachusetts Drug Stewardship Program

1/18/2017
  • Drug Control Program
  • Bureau of Health Care Safety and Quality
  • Bureau of Health Professions Licensure

Circular letter

TO: Pharmaceutical Drug Manufacturers

FROM: Eric Sheehan, Director, Bureau of Health Care Safety and Quality
James Lavery, Director, Bureau of Health Professions Licensure

DATE: January 18, 2017

RE: Massachusetts Drug Stewardship Program

Additional Resources   for Circular letter: 17-1-666 Massachusetts Drug Stewardship Program

Open PDF file, 184.53 KB,  Circular letter: 17-1-666 Massachusetts Drug Stewardship Program – 1/18/2017 (PDF 184.53 KB)
Open DOCX file, 48.62 KB,  Circular letter: 17-1-666 Massachusetts Drug Stewardship Program – 1/18/2017 (DOCX 48.62 KB)

  • Drug Control Program 

    We promote access to safe and effective pharmaceutical care services in Massachusetts. We work to protect consumers against fraud, deception, and unsafe practices in the distribution, handling, and use of pharmaceuticals and medical devices.

  • Bureau of Health Care Safety and Quality 

    BHCSQ promotes, preserves, and protects the health of all people in the Commonwealth by ensuring an optimal health care delivery system that provides safe, effective, high-quality care.

  • Bureau of Health Professions Licensure 

    BHPL oversees the licensing of health care professionals in the state of Massachusetts.

    • Help Us Improve Mass.gov  with your feedback

    Please do not include personal or contact information.
    Feedback